Microbiology Quiz: Enzymatic Degradation
20 questions · exam conditions
0:00
Enzymatic DegradationQuestion 1 of 20

A clinical isolate of Klebsiella pneumoniae shows resistance to ceftriaxone and ceftazidime. A combination disk test reveals that the zone of inhibition for ceftazidime increases by >5 mm when tested with clavulanic acid. The isolate remains resistant to cefoxitin. What is the most likely mechanism of beta-lactam resistance in this isolate?

Production of an extended-spectrum beta-lactamase (ESBL).
Overexpression of a chromosomal AmpC beta-lactamase.
Production of a KPC-type carbapenemase.
Porin channel mutation combined with a narrow-spectrum penicillinase.
← Back to quizzes

Microbiology Quiz

Microbiology Quiz: Enzymatic Degradation

Practice Enzymatic Degradation in Microbiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Enzymatic Degradation, giving you a quick way to practice the rules, question types, and explanations that matter most for Microbiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A clinical isolate of Klebsiella pneumoniae shows resistance to ceftriaxone and ceftazidime. A combination disk test reveals that the zone of inhibition for ceftazidime increases by >5 mm when tested with clavulanic acid. The isolate remains resistant to cefoxitin. What is the most likely mechanism of beta-lactam resistance in this isolate?

  1. Production of an extended-spectrum beta-lactamase (ESBL). (correct answer)
  2. Overexpression of a chromosomal AmpC beta-lactamase.
  3. Production of a KPC-type carbapenemase.
  4. Porin channel mutation combined with a narrow-spectrum penicillinase.
Explanation: The key finding is the synergy between ceftazidime and clavulanic acid, which is the classic phenotypic definition of an ESBL. ESBLs hydrolyze extended-spectrum cephalosporins (like ceftriaxone and ceftazidime) and are inhibited by clavulanic acid. AmpC beta-lactamases (B) are not inhibited by clavulanic acid and typically confer resistance to cefoxitin. KPC carbapenemases (C) would confer resistance to carbapenems (not tested here), and while some are inhibited by clavulanate, the overall pattern is more typical for an ESBL. Porin mutations (D) would not show synergy with clavulanic acid.

Question 2

The enzymatic activity of beta-lactamase involves hydrolysis of the amide bond within the four-membered beta-lactam ring. What structural feature of this ring makes this bond particularly susceptible to hydrolysis compared to a typical linear amide?

  1. The sulfur atom in the adjacent thiazolidine ring withdraws electron density from the amide bond.
  2. Significant geometric ring strain forces the amide bond to be non-planar, increasing its reactivity. (correct answer)
  3. The adjacent carboxyl group acts as an intramolecular catalyst, promoting its own hydrolysis.
  4. The beta-lactam ring is a zwitterion at physiological pH, facilitating entry into the enzyme's active site.
Explanation: The primary reason for the high reactivity of the beta-lactam amide bond is ring strain. In a stable, linear amide, the nitrogen atom's lone pair of electrons delocalizes into the carbonyl group, creating resonance stabilization and a planar geometry. The geometric constraints of the small, four-membered ring prevent this ideal planarity and resonance. This makes the carbonyl carbon more electrophilic (more ketone-like) and the amide bond weaker, rendering it highly susceptible to nucleophilic attack by the beta-lactamase enzyme.

Question 3

A carbapenem-resistant Enterobacter cloacae isolate is found to have a mutation leading to the loss of a major outer membrane porin channel. Additionally, it expresses its chromosomal AmpC beta-lactamase at basal, uninduced levels. What is the most likely role of the AmpC enzyme in this isolate's carbapenem resistance?

  1. The AmpC enzyme has mutated to gain high-level carbapenemase activity, serving as the primary resistance mechanism.
  2. The AmpC enzyme has no role; resistance is solely due to the lack of carbapenem entry through the lost porin.
  3. Porin loss reduces the rate of carbapenem entry, allowing the weak intrinsic carbapenemase activity of AmpC to be effective. (correct answer)
  4. The loss of the porin signals a stress response that causes massive overexpression of the AmpC enzyme.
Explanation: This is a classic example of synergistic resistance. Wild-type AmpC has very poor hydrolytic activity against carbapenems. Porin loss alone typically only causes a small increase in the carbapenem MIC. However, when combined, the two mechanisms lead to clinical resistance. The porin loss acts as a barrier, slowing the influx of carbapenem into the periplasmic space. This reduced rate of entry allows the low-level but present AmpC enzyme sufficient time to hydrolyze the few drug molecules that do enter, preventing them from reaching their PBP targets.

Question 4

Avibactam is a diazabicyclooctane beta-lactamase inhibitor that restores the activity of ceftazidime against many resistant Gram-negative bacteria. A bacterial isolate that possesses a beta-lactamase that is NOT inhibited by avibactam is identified. This enzyme is most likely a(n):

  1. CTX-M-15 (an ESBL).
  2. KPC-2 (a carbapenemase).
  3. AmpC (a cephalosporinase).
  4. NDM-1 (a metallo-beta-lactamase). (correct answer)
Explanation: Avibactam has a broad spectrum of activity against serine beta-lactamases, including Class A enzymes (like ESBLs and KPC carbapenemases) and Class C enzymes (AmpC). However, it is completely ineffective against Class B enzymes, the metallo-beta-lactamases (MBLs) like NDM-1, VIM, and IMP. MBLs use a zinc-dependent mechanism for hydrolysis, which is fundamentally different from the serine-based mechanism targeted by avibactam. Therefore, resistance to a ceftazidime-avibactam combination strongly suggests the presence of an MBL.

Question 5

A rapid test for beta-lactamase detection uses the chromogenic cephalosporin nitrocefin. When a beta-lactamase-producing bacterial colony is applied, the nearly colorless substrate solution turns red. What is the biochemical event that directly causes this color change?

  1. Enzyme binding causes a conformational change in nitrocefin, shifting its light absorption spectrum.
  2. Hydrolysis of the beta-lactam ring disrupts the molecule's electron conjugation system, creating a colored product. (correct answer)
  3. The enzyme reduces a nitro group on the cephalosporin molecule to a highly colored amino group.
  4. The pH change from hydrolysis causes a pH indicator dye mixed with the substrate to turn red.
Explanation: The color change of nitrocefin is intrinsic to the molecule's structure. In its intact form, it has a specific system of conjugated double bonds that absorbs light outside the visible spectrum (appearing yellowish). When a beta-lactamase hydrolyzes the amide bond in the beta-lactam ring, the ring opens. This cleavage causes a rearrangement of the molecule's electronic structure, extending the system of conjugation. This altered conjugated system now absorbs light in the visible range, causing the compound to appear red. The event is a direct result of enzymatic bond cleavage, not just binding (A), reduction (C), or an external pH indicator (D).

Question 6

A novel beta-lactamase inhibitor is found to bind irreversibly to the active site of a TEM-1 beta-lactamase only after the enzyme initiates catalysis on the inhibitor molecule. This inhibitor shows a high affinity for the enzyme but is turned over very slowly. How would this inhibitor be best classified based on its kinetic properties?

  1. A competitive inhibitor with a high KiK_i.
  2. A non-competitive inhibitor that binds to an allosteric site.
  3. A mechanism-based inactivator, or 'suicide inhibitor'. (correct answer)
  4. An uncompetitive inhibitor that binds only to the enzyme-substrate complex.
Explanation: The description perfectly matches that of a mechanism-based inactivator, also known as a suicide inhibitor. The enzyme binds the inhibitor as if it were a substrate, and the catalytic mechanism itself converts the inhibitor into a reactive species that then covalently and irreversibly inactivates the enzyme. This is the mechanism of action for inhibitors like clavulanic acid. A high KiK_i (A) indicates low affinity. The inhibitor binds to the active site, not an allosteric site (B).

Question 7

A Pseudomonas aeruginosa isolate from a cystic fibrosis patient has the following MICs: Piperacillin/Tazobactam >256/4 µg/mL, Ceftazidime >64 µg/mL, Ceftazidime/Avibactam 16 µg/mL, Meropenem 16 µg/mL, Aztreonam 8 µg/mL. Which combination of resistance mechanisms is most consistent with this antibiogram?

  1. Overexpression of a TEM-type ESBL and an outer membrane porin mutation.
  2. Production of a metallo-beta-lactamase (MBL) and active efflux pump overexpression. (correct answer)
  3. A derepressed chromosomal AmpC beta-lactamase and a target site mutation.
  4. Production of a KPC-type carbapenemase.
Explanation: The key features are resistance to a carbapenem (meropenem) and retained susceptibility to aztreonam. This pattern is pathognomonic for a metallo-beta-lactamase (MBL, Ambler Class B), as MBLs hydrolyze all beta-lactams including carbapenems except for the monobactam aztreonam. KPC (D) and most ESBLs (A) would be expected to hydrolyze aztreonam. Avibactam does not inhibit MBLs, which is consistent with the ceftazidime/avibactam MIC remaining elevated. Efflux pumps commonly contribute to the high-level resistance observed in P. aeruginosa.

Question 8

Two carbapenem-resistant K. pneumoniae isolates are being investigated. Isolate 1 is highly resistant to both ertapenem and meropenem. Isolate 2 is highly resistant to ertapenem but shows only low-level resistance to meropenem. Furthermore, Isolate 2 is highly resistant to temocillin. Which of the following is the most likely identity of the carbapenemases?

  1. Isolate 1: KPC; Isolate 2: MBL
  2. Isolate 1: OXA-48; Isolate 2: KPC
  3. Isolate 1: KPC; Isolate 2: OXA-48 (correct answer)
  4. Both isolates: Derepressed AmpC with porin loss
Explanation: KPC (a Class A carbapenemase) typically confers high-level resistance to all carbapenems, including ertapenem and meropenem, matching Isolate 1. OXA-48 (a Class D carbapenemase) has a distinctive hydrolysis profile: it is a potent ertapenemase but hydrolyzes imipenem and meropenem much more weakly. This leads to the characteristic phenotype of high-level ertapenem resistance with much lower-level resistance to other carbapenems, matching Isolate 2. High-level resistance to temocillin is also a hallmark of OXA-48-like enzymes.

Question 9

Vaborbactam is a non-beta-lactam beta-lactamase inhibitor that utilizes a boronic acid moiety and is highly effective against KPC-type carbapenemases. What is the primary mechanism by which vaborbactam inhibits serine beta-lactamases like KPC?

  1. It acts as a chelating agent, removing the zinc ions essential for KPC enzymatic activity.
  2. It forms a stable, reversible covalent bond with the active site serine residue, mimicking the hydrolysis transition state. (correct answer)
  3. It allosterically binds to KPC, inducing a conformational change that closes the active site to substrates.
  4. It is a suicide inhibitor that is processed by KPC into a reactive species, which then permanently alkylates the enzyme.
Explanation: Boronic acid inhibitors like vaborbactam work by forming a dative covalent bond between the boron atom and the hydroxyl oxygen of the active site serine residue in serine beta-lactamases (like KPC). This complex is very stable and mimics the tetrahedral transition state of beta-lactam hydrolysis, effectively trapping the enzyme in an inactive form. The inhibition is covalent but typically reversible. It does not chelate zinc (A), as KPC is a serine, not metallo, enzyme. It is an active-site inhibitor, not allosteric (C). Its mechanism is distinct from suicide inhibitors like clavulanate (D).

Question 10

An E. coli isolate is resistant to amoxicillin-clavulanate. Genetic analysis reveals it produces a TEM-1 beta-lactamase, which is normally susceptible to clavulanate. Which of the following is the most plausible additional mechanism accounting for the observed resistance?

  1. A mutation in the TEM-1 active site that reduces affinity for clavulanate while maintaining penicillinase activity. (correct answer)
  2. A mutation in the gene for penicillin-binding protein 3 (PBP3), making it a poor target for amoxicillin.
  3. Massive hyperproduction of the TEM-1 enzyme, which titrates out the available clavulanate inhibitor.
  4. Acquisition of a secondary plasmid encoding a distinct, clavulanate-resistant AmpC beta-lactamase.
Explanation: When an organism producing a typically inhibitor-susceptible enzyme becomes resistant to the inhibitor combination, one must consider mechanisms of inhibitor resistance. Point mutations in the active site of the TEM enzyme can lead to the formation of an inhibitor-resistant TEM (IRT) beta-lactamase. These mutations selectively decrease the binding affinity of the inhibitor (clavulanate) without significantly compromising the enzyme's ability to hydrolyze the substrate (amoxicillin). While hyperproduction (C) is also a valid mechanism, specific mutational changes conferring inhibitor resistance are a well-described and direct cause for this phenotype.

Question 11

An Escherichia coli isolate is resistant to gentamicin and tobramycin but remains susceptible to amikacin. Analysis reveals the presence of an aminoglycoside nucleotidyltransferase (ANT). Which statement best explains this resistance pattern?

  1. The ANT enzyme modifies gentamicin and tobramycin by nucleotidylation, preventing ribosomal binding and reducing their antimicrobial efficacy.
  2. The enzyme phosphorylates hydroxyl groups on amikacin preferentially, but shows minimal activity against gentamicin or tobramycin.
  3. Steric hindrance from amikacin's L-hydroxyaminobutyryl amide (L-HABA) side chain prevents the ANT from modifying the drug. (correct answer)
  4. The ANT enzyme cleaves glycosidic bonds in gentamicin and tobramycin, fragmenting them before they reach the ribosomal target site.
Explanation: Aminoglycoside resistance is often due to enzymatic modification. Many common modifying enzymes (acetyltransferases, phosphotransferases, nucleotidyltransferases) are unable to bind and modify amikacin due to the bulky L-HABA side chain attached to the N1 position. This side chain provides steric protection, preserving amikacin's activity against organisms that produce such enzymes. The enzyme modifies the drug to prevent ribosomal binding, it doesn't hydrolyze it (D). ANT enzymes add nucleotide groups, not acetyl (A) or phosphate (B) groups.

Question 12

A patient with a complicated urinary tract infection caused by Enterobacter cloacae is initially treated with ceftriaxone, based on a susceptibility report showing the isolate is sensitive. After three days of therapy, the patient's condition worsens. A repeat culture shows the E. cloacae is now resistant to ceftriaxone, ceftazidime, and piperacillin-tazobactam, but remains susceptible to imipenem.

What is the most likely explanation for the development of this resistance profile?

  1. Acquisition of a plasmid carrying an ESBL gene via horizontal gene transfer.
  2. Selection of a subpopulation with a stable derepressed AmpC beta-lactamase. (correct answer)
  3. Development of a point mutation in the penicillin-binding proteins (PBPs).
  4. Emergence of a carbapenemase-producing strain.
Explanation: Enterobacter species possess an inducible chromosomal AmpC beta-lactamase. Treatment with potent inducers like third-generation cephalosporins (e.g., ceftriaxone) can select for mutants that constitutively overexpress (derepress) AmpC. This results in resistance to most penicillins and cephalosporins, including beta-lactamase inhibitor combinations like piperacillin-tazobactam. Continued susceptibility to imipenem makes a carbapenemase (D) unlikely. Resistance to piperacillin-tazobactam makes a typical ESBL (A) less likely than derepressed AmpC.

Question 13

A Pseudomonas aeruginosa isolate from a cystic fibrosis patient has the following MICs: Piperacillin/Tazobactam >256/4 µg/mL, Ceftazidime >64 µg/mL, Ceftazidime/Avibactam 16 µg/mL, Meropenem 16 µg/mL, Aztreonam 8 µg/mL. Which combination of resistance mechanisms is most consistent with this antibiogram?

  1. Overexpression of a TEM-type ESBL and an outer membrane porin mutation.
  2. Production of a metallo-beta-lactamase (MBL) and active efflux pump overexpression. (correct answer)
  3. A derepressed chromosomal AmpC beta-lactamase and a target site mutation.
  4. Production of a KPC-type carbapenemase.
Explanation: The key features are resistance to a carbapenem (meropenem) and retained susceptibility to aztreonam. This pattern is pathognomonic for a metallo-beta-lactamase (MBL, Ambler Class B), as MBLs hydrolyze all beta-lactams including carbapenems except for the monobactam aztreonam. KPC (D) and most ESBLs (A) would be expected to hydrolyze aztreonam. Avibactam does not inhibit MBLs, which is consistent with the ceftazidime/avibactam MIC remaining elevated. Efflux pumps commonly contribute to the high-level resistance observed in P. aeruginosa.

Question 14

An unknown beta-lactamase is purified from a clinical isolate of Pseudomonas aeruginosa. It is shown to efficiently hydrolyze cefepime and meropenem but has minimal activity against aztreonam. The enzyme's activity is significantly reduced in the presence of dipicolinic acid. This enzyme is most likely a(n):

  1. Extended-spectrum beta-lactamase (ESBL).
  2. KPC-type carbapenemase.
  3. OXA-48-like carbapenemase.
  4. Metallo-beta-lactamase (MBL). (correct answer)
Explanation: This profile is characteristic of a metallo-beta-lactamase (MBL, Class B). MBLs have a broad substrate profile that includes carbapenems (meropenem) and advanced-generation cephalosporins (cefepime). A key identifying feature is their inability to hydrolyze the monobactam aztreonam. Furthermore, as they are zinc-dependent enzymes, their activity is inhibited by metal chelators like dipicolinic acid or EDTA. ESBLs (A) do not hydrolyze carbapenems. KPC (B) and OXA-48 (C) are serine-based enzymes not inhibited by chelators, and KPC readily hydrolyzes aztreonam.

Question 15

An E. coli isolate is resistant to amoxicillin-clavulanate. Genetic analysis reveals it produces a TEM-1 beta-lactamase, which is normally susceptible to clavulanate. Which of the following is the most plausible additional mechanism accounting for the observed resistance?

  1. A mutation in the TEM-1 active site that reduces affinity for clavulanate while maintaining penicillinase activity. (correct answer)
  2. A mutation in the gene for penicillin-binding protein 3 (PBP3), making it a poor target for amoxicillin.
  3. Massive hyperproduction of the TEM-1 enzyme, which titrates out the available clavulanate inhibitor.
  4. Acquisition of a secondary plasmid encoding a distinct, clavulanate-resistant AmpC beta-lactamase.
Explanation: When an organism producing a typically inhibitor-susceptible enzyme becomes resistant to the inhibitor combination, one must consider mechanisms of inhibitor resistance. Point mutations in the active site of the TEM enzyme can lead to the formation of an inhibitor-resistant TEM (IRT) beta-lactamase. These mutations selectively decrease the binding affinity of the inhibitor (clavulanate) without significantly compromising the enzyme's ability to hydrolyze the substrate (amoxicillin). While hyperproduction (C) is also a valid mechanism, specific mutational changes conferring inhibitor resistance are a well-described and direct cause for this phenotype.

Question 16

A carbapenem-resistant Enterobacter cloacae isolate is found to have a mutation leading to the loss of a major outer membrane porin channel. Additionally, it expresses its chromosomal AmpC beta-lactamase at basal, uninduced levels. What is the most likely role of the AmpC enzyme in this isolate's carbapenem resistance?

  1. The AmpC enzyme has mutated to gain high-level carbapenemase activity, serving as the primary resistance mechanism.
  2. The AmpC enzyme has no role; resistance is solely due to the lack of carbapenem entry through the lost porin.
  3. Porin loss reduces the rate of carbapenem entry, allowing the weak intrinsic carbapenemase activity of AmpC to be effective. (correct answer)
  4. The loss of the porin signals a stress response that causes massive overexpression of the AmpC enzyme.
Explanation: This is a classic example of synergistic resistance. Wild-type AmpC has very poor hydrolytic activity against carbapenems. Porin loss alone typically only causes a small increase in the carbapenem MIC. However, when combined, the two mechanisms lead to clinical resistance. The porin loss acts as a barrier, slowing the influx of carbapenem into the periplasmic space. This reduced rate of entry allows the low-level but present AmpC enzyme sufficient time to hydrolyze the few drug molecules that do enter, preventing them from reaching their PBP targets.

Question 17

A rapid test for beta-lactamase detection uses the chromogenic cephalosporin nitrocefin. When a beta-lactamase-producing bacterial colony is applied, the nearly colorless substrate solution turns red. What is the biochemical event that directly causes this color change?

  1. Enzyme binding causes a conformational change in nitrocefin, shifting its light absorption spectrum.
  2. Hydrolysis of the beta-lactam ring disrupts the molecule's electron conjugation system, creating a colored product. (correct answer)
  3. The enzyme reduces a nitro group on the cephalosporin molecule to a highly colored amino group.
  4. The pH change from hydrolysis causes a pH indicator dye mixed with the substrate to turn red.
Explanation: The color change of nitrocefin is intrinsic to the molecule's structure. In its intact form, it has a specific system of conjugated double bonds that absorbs light outside the visible spectrum (appearing yellowish). When a beta-lactamase hydrolyzes the amide bond in the beta-lactam ring, the ring opens. This cleavage causes a rearrangement of the molecule's electronic structure, extending the system of conjugation. This altered conjugated system now absorbs light in the visible range, causing the compound to appear red. The event is a direct result of enzymatic bond cleavage, not just binding (A), reduction (C), or an external pH indicator (D).

Question 18

A microbiologist is investigating resistance mechanisms in a variety of clinical isolates. For which antibiotic-organism pair is enzymatic degradation of the drug LEAST likely to be the primary mechanism of resistance?

  1. Gentamicin resistance in Enterococcus faecalis
  2. Penicillin G resistance in Staphylococcus aureus
  3. Erythromycin resistance in Streptococcus pneumoniae (correct answer)
  4. Imipenem resistance in Klebsiella pneumoniae
Explanation: While several mechanisms can contribute, the most common and clinically significant form of high-level macrolide (e.g., erythromycin) resistance in Gram-positive cocci like Streptococcus pneumoniae is target site modification. This is mediated by an Erm methylase, which dimethylates an adenine residue in the 23S rRNA, preventing the drug from binding to the ribosome. In contrast, penicillinase (B), aminoglycoside-modifying enzymes (A), and carbapenemases (D) are all very common and primary mechanisms of enzymatic drug degradation for their respective drug-organism pairs.

Question 19

Avibactam is a diazabicyclooctane beta-lactamase inhibitor that restores the activity of ceftazidime against many resistant Gram-negative bacteria. A bacterial isolate that possesses a beta-lactamase that is NOT inhibited by avibactam is identified. This enzyme is most likely a(n):

  1. CTX-M-15 (an ESBL).
  2. KPC-2 (a carbapenemase).
  3. AmpC (a cephalosporinase).
  4. NDM-1 (a metallo-beta-lactamase). (correct answer)
Explanation: Avibactam has a broad spectrum of activity against serine beta-lactamases, including Class A enzymes (like ESBLs and KPC carbapenemases) and Class C enzymes (AmpC). However, it is completely ineffective against Class B enzymes, the metallo-beta-lactamases (MBLs) like NDM-1, VIM, and IMP. MBLs use a zinc-dependent mechanism for hydrolysis, which is fundamentally different from the serine-based mechanism targeted by avibactam. Therefore, resistance to a ceftazidime-avibactam combination strongly suggests the presence of an MBL.

Question 20

A multidrug-resistant Acinetobacter baumannii isolate is found to be resistant to imipenem. Phenotypic testing shows that its carbapenemase activity is not inhibited by either EDTA or clavulanic acid. Based on these findings, the carbapenemase most likely belongs to which Ambler class?

  1. Class A
  2. Class B
  3. Class C
  4. Class D (correct answer)
Explanation: Carbapenemase classes are differentiated by their inhibitor profiles. Class A carbapenemases (e.g., KPC) are often inhibited by clavulanic acid. Class B enzymes are metallo-beta-lactamases and are inhibited by the chelating agent EDTA. Class C enzymes (AmpC) are typically not potent carbapenemases. Class D enzymes, the OXA-type carbapenemases, are serine-based but are characteristically not inhibited by either clavulanic acid or EDTA. OXA-type carbapenemases are very common in Acinetobacter baumannii.